14 research outputs found
364 SELECTIVE INHIBITION OF AGGRECANASE PREVENTS AGGRECAN DEGRADATION AND PROMOTES INCORPORATION OF NEWLY SYNTHESIZED AGGRECAN INTO THE EXTRACELLULAR MATRIX OF HUMAN OSTEOARTHRITIC CARTILAGE
Get PDF28 TENASCIN-C LEVELS IN SYNOVIAL FLUID ARE ELEVATED AFTER HUMAN JOINT INJURY AND CORRELATE WITH MARKERS OF MATRIX DEGRADATION AND INFLAMMATION
No full text99 A SENSITIVE AGGRECANASE ASSAY FOR IN-VITRO/CELLULAR ACTIVITIES AND FOR TESTING BIOLOGICAL SAMPLES
No full text062 INDUCTION OF INFLAMMATORY MEDIATORS AND MATRIX DEGRADATION IN ARTICULAR CARTILAGE BY TENASCIN-C AND TLR4 SIGNALING
No full text114 TENASCIN-C LARGE, AN ELASTIC PROTEIN INDICATING JOINT DISEASE/INJURY IN HUMANS & PRECLINICAL ANIMAL MODELS
No full textOptimization of stereolithography process parameters for part strength using design of experiments
No full text364 SELECTIVE INHIBITION OF AGGRECANASE PREVENTS AGGRECAN DEGRADATION AND PROMOTES INCORPORATION OF NEWLY SYNTHESIZED AGGRECAN INTO THE EXTRACELLULAR MATRIX OF HUMAN OSTEOARTHRITIC CARTILAGE
No full text049 JOINT INJURY LEADS TO SIGNIFICANTLY INCREASED AGGRECANASE ACTIVITY IN HUMANS AND PRECLINICAL ANIMAL MODELS
No full text473 ATTENUATION OF RETINOIC ACID-INDUCED AGGRECAN CATABOLISM IN RAT CARTILAGE EXPLANTS BY AN AGGRECANASE SELECTIVE INHIBITOR
No full textTenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation
No full text
